Cite Filings / OTLK / 0001209191-20-025300
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
3

Initial Statement of Ownership

Outlook Therapeutics, Inc. · Filed 2020-04-21 · Acc 0001209191-20-025300

Documents 1

  • 3 Initial Statement of Ownership , xslF345X02/doc3.xml

Around this filing

  • 2020-04-21 4 Chief Commercial Officer acquired 1,207,457 shares (grant or award)
  • 2020-04-21 4 Chief Operating Officer acquired 1,207,457 shares (grant or award)
  • 2020-04-21 4 Options or other derivatives
  • 2020-04-21 3 Initial Statement of Ownership
  • 2020-04-21 3 Initial Statement of Ownership
  • 2020-04-21 8-K Executive or director change
  • 2020-02-27 3 Initial Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslF345X02/doc3.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…